海外の治験の状況「前立腺癌」での検索結果
403件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- focal radiotherapy for previously treated prostate cancer patients
- locally recurrent prostate cancer following definitive external beam radiotherapy
- Australia
- 2017-01-09
Not recruiting
- ODM-201 in Addition to Standard ADT and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
- Prostatic Neoplasms
- Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Czechia, Finland, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2016-06-06
Not recruiting
- Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer
- Prostate Cancer
- Australia, Ireland, New Zealand, United Kingdom, United States of America
- 2014-02-03
Authorised
- An Investigational Immunotherapy Study to Determine Which Combination of Nivolumab plus Several Other Drugs, is the Most Effective in Treating Castration-resistant Prostate Cancer That Has Spread
- Castration-resistant Metastatic Prostate Cancer br>MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Mexico, Spain
- 2017-12-01
Recruiting
- TheraP: A randomised phase 2 trial of 177-Lutetium-Prostate Specific Membrane Antigen-617 (177Lu-PSMA617) theranostic versus cabazitaxel in progressive metastatic castration resistant prostate cancer (ANZUP1603)
- Prostate cancer
- Australia
- 2017-11-29
Authorised
- A study to provide access to continued treatment for subjects with prostate cancer who are currently participating in an enzalutamide clinical study
- metastatic castration-resistant prostate cancer br>MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belgium, Canada, Chile, Czech Republic, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Japan, Korea, Republic of, Lithuania, Moldova, Republic of, Netherlands, New Zealand, Russian Federation, Slovakia, South Africa, Spain, Sweden, Taiwan, United Kingdom, United States
- 2016-09-30
Recruiting
- EX-HEART TRIAL: Exercise for heart health in prostate cancer
- Prostate cancer;Cardiovascular disease; Prostate cancer br>Cardiovascular disease;Cardiovascular - Normal development and function of the cardiovascular system;Cancer - Prostate
- Australia
- 2018-07-13
Not Recruiting
- The effects of creatine supplementation and weight training on muscle mass in individuals with prostate cancer undergoing androgen deprivation therapy.
- Prostate Cancer; br>Prostate Cancer;Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation;Cancer - Prostate
- Australia
- 2019-01-23
Not recruiting
- Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Brazil, China, Korea, Republic of, Kuwait, Lebanon, New Zealand, Saudi Arabia, Taiwan, Thailand
- 2005-10-19
Recruiting
- A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
- Prostate Cancer
- Australia, Austria, Belgium, Brazil, Canada, Denmark, Finland, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Slovakia, Spain, Sweden, Taiwan, United Kingdom, United States
- 2017-03-09